LISA PREWITT: Open Payments
NPI 1538148200 · BURLINGTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 14 payments from 8 companies in 2025. Trend: 2023 $312 · 2024 $58 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $150 |
| Novo Nordisk Inc | 1 | $111 |
| ABBVIE INC. | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: NURTEC ODT, Wegovy, AUSTEDO XR, JOURNAVX, UBRELVY, VRAYLAR, INVEGA SUSTENNA, CAPLYTA.
Industry payments across IA — which companies pay providers there.
